Wake-Up Call: FDA Pushes Drugmakers To Weaken Sleeping Pills | WAMU 88.5 - American University Radio
Filed Under:

Wake-Up Call: FDA Pushes Drugmakers To Weaken Sleeping Pills

Play associated audio

The Food and Drug Administration announced Thursday that it was requiring companies that make Ambien and similar sleeping pills to sharply cut the doses of the drugs.

The agency says it is taking the step for the brands Ambien, Ambien CR, Edluar and Zolpimist, as well as generic versions of Ambien, because tests showed the active ingredient in the medications, zolpidem, stays in the body longer than had been thought. That raises the possibility that people taking the drugs will remain drowsy the next day, making activities such as driving and operating heavy machinery dangerous.

"To decrease the potential risk of impairment with all insomnia drugs, health care professionals should prescribe and patients should take the lowest dose capable of treating the patient's insomnia," Ellis Unger, director of the FDA's Center for Drug Evaluation and Research, said in the statement.

The problem is especially a concern for women because the drug tends to stay in their bodies longer than it does in men, the FDA says.

As a result, the FDA is ordering companies to cut the dose for women from 10 milligrams to 5 milligrams for immediate-release products — which include Ambien, Edluar and Zolpimist — and from 12.5 milligrams to 6.25 milligrams for the extended-release product Ambien CR.

In addition, the FDA ordered companies to change the labeling on the drug for men, recommending doctors consider prescribing the same lower doses for them.

"Patients who must drive in the morning or perform some other activity requiring full alertness should talk to their health care professional about whether their sleep medicine is appropriate," Unger says.

The move does not affect other popular sleeping pills that contain different active ingredients, such as Lunesta and Sonata. But in an interview with NPR, Unger said the agency is evaluating those as well.

The agency has long known that all these products can leave people drowsy in the morning, says Unger, and there have been about 700 reports of people getting in traffic accidents after taking them.

About 40 million prescriptions for drugs containing zolpidem were dispensed in 2011, making them the most widely used sleeping pills, according to IMS Health, which monitors drug sales.

Copyright 2013 National Public Radio. To see more, visit http://www.npr.org/.

WAMU 88.5

'Historic Landmark' Status Complicates Corcoran Renovations

Plans by George Washington University to renovate the Corcoran Gallery of Art may be thrown for a loop after D.C.'s historic preservation board designated much of the interior of the building as a historic landmark.

NPR

In This Museum, Visitors Can Eat At The Exhibits

The Southern Museum of Food and Beverage in New Orleans chronicles the eats and drinks of the Southern states. And it may be one of the only museums where visitors can imbibe while viewing exhibits.
NPR

Staten Island Candidates Avoid Talk Of Eric Garner Case

In the New York Congressional district where an an unarmed black man died at the hands of police last year, neither candidate for a special congressional election is using the death to score points.
NPR

As Health Apps Hop On The Apple Watch, Privacy Will Be Key

The notion of receiving nutrition advice from artificial intelligence on your wrist may seem like science fiction. But health developers are betting this kind of behavior will become the norm.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.